Prostate cancer and neuroendocrine differentiation.
- 1 January 1999
- journal article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 31 (1) , 75-82
- https://doi.org/10.1023/a:1007175924082
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Prognostic Value of Neuroendocrine Differentiation in Adenocarcinoma of the Prostate in Relation to Progression of Disease After Endocrine TherapyJournal of Urology, 1997
- Are neuroendocrine cells of practical value as an independent prognostic parameter in prostate cancer?British Journal of Urology, 1995
- Neuro‐endocrine Cells—A New Prognostic Parameter in Prostate CancerBritish Journal of Urology, 1991
- Androgen receptor expression in human tissues: an immunohistochemical study.Journal of Histochemistry & Cytochemistry, 1991
- Androgen receptors in endocrine‐therapy‐resistant human prostate cancerInternational Journal of Cancer, 1991
- Relation of endocrine‐paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostateThe Prostate, 1991
- Prostatic Carcinoma: Histological and Immunohistological Factors Affecting PrognosisBritish Journal of Urology, 1990
- Peptide-hormone- and serotonin-immunoreactive cells in normal and hyperplastic prostate glandsPathology - Research and Practice, 1986
- Argentaffin and argyrophil cells in the prostateThe Journal of Pathology, 1974
- Argentaffin cells in prostatic carcinoma: Differentiation from lipofuscin and melanin in prostatic epitheliumThe Journal of Pathology, 1971